Xcout Intel
Oviva
Oviva Therapeutics is a biotechnology research subsidiary headquartered in New York, NY, focused on women's health. The company develops novel therapeutics designed to target ovarian function and extend healthspan.
Subscribe to see Oviva’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Oviva at a glance
Oviva is a healthtech company. Its most recent funding round, Series D, raised $200M in January 2026. Xcout tracks 2 named people at Oviva, including Kai Eberhardt (co-founder). Xcout recorded 47 job postings from Oviva in the last 90 days, naming tools such as Salesforce, Claude, Cursor.
Oviva leadership
- Kai Eberhardtco-founder
- Manuel Baumannco-founder
Oviva funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series D | $200M | 7 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Oviva
Xcout recorded 47 job postings from Oviva in the last 90 days, from a hiring record Xcout has kept since August 2026.
Tools named in Oviva's job postings
The weekly hiring trend, the roles and locations behind it — see Oviva's hiring signals →
Investors
Tech stack
Oviva competitors
A few of Oviva's closest competitors — see the full list of competitors and alternatives →
Ovo Labs is a biotechnology research company headquartered in Munich, Germany, that pioneers therapeutics designed to boost egg quality and enhance IVF success.
Oriva Therapeutics is a biotechnology and pharmaceutical company headquartered in Barcelona, Spain. The venture is dedicated to advancing innovative and disease-modifying approaches to improve clinical outcomes for chronic women's health conditions.
Gameto, Inc. is a biotechnology research company with corporate locations in Austin, Texas, and New York, New York. The firm focuses on biotechnology innovations aimed at revolutionizing reproductive health and ovarian biology.
ObsEva is a biopharmaceutical company headquartered in Geneva, Switzerland, specifically in Plan-les-Ouates. The company focuses on developing and commercializing novel therapies for women's reproductive health. ObsEva has entered into global license agreements, such as with Organon, for the development of certain compounds.
Cyclana Bio is a biotechnology company headquartered in Cambridge, United Kingdom, pioneering tissue-level approaches to advance drug discovery and uncover mechanisms in women's health.
JumpStart Fertility develops metabolic solutions designed to improve oocyte quality and IVF success rates for women experiencing declining fertility due to advanced maternal age. Their patent-protected compound integrates into existing in vitro fertilisation workflows with the aim of increasing blastocyst formation rates.
Get Oviva's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Oviva in Xcout Intel
- 2 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access